Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-10-09Clinical Trial Update: MLD10 in the Prevention of Migraine in Adults [Phase 2, Phase 3]
A Phase 2/Phase 3 trial update for MLD10 in preventing migraine in adults has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: Efficacy of OnabotulinumtoxinA in Migraine [Phase 2]
A Phase 2 study evaluating the efficacy of onabotulinumtoxinA for migraine has completed.
-
FDA approval · 2020-10-06FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Rizatriptan Benzoate from Rising Pharma Holdings, Inc., authorizing the generic Rizatriptan …
-
FDA approval · 2020-09-30FDA Approved: ELETRIPTAN HYDROBROMIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Eletriptan hydrobromide from Mylan Pharmaceuticals Inc., authorizing a generic version for t…
-
FDA approval · 2020-09-29FDA Approved: ALMOTRIPTAN MALATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for Almotriptan Malate (Teva Pharmaceuticals USA, Inc.), granting regulatory approval for this gener…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-09-21FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Rizatriptan Benzoate from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2020-09-21FDA Approved: SUMATRIPTAN — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approves Padagis Israel Pharmaceuticals Ltd's SUMATRIPTAN as an original ANDA generic for the acute treatment of migraines.
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine [Phase 2]
Phase 2 dose-ranging trial of rimegepant (BMS-927711) for acute treatment of migraine has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-01Clinical Trial Update: A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine [Phase 1]
Phase 1 study assessing lasmiditan in children 6 to 17 with migraine has completed; results posted in 2020.
-
FDA approval · 2020-08-25FDA Approved: SUMATRIPTAN — Supplemental Application (Eugia US LLC)
The FDA approved a supplemental application for Sumatriptan submitted by Eugia US LLC. This pertains to an existing Sumatriptan product.
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine [Phase 3]
Phase 3 trial update of galcanezumab in Japanese participants with migraine has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine [Phase 3]
Phase 3 trial evaluating long-term safety of M207 for acute treatment of migraine has completed with results posted.
-
FDA approval · 2020-08-18FDA Approved: NURTEC ODT — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Nurtec ODT (rimegepant sulfate) from Pfizer Laboratories Div Pfizer Inc, updating the drug's…
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: Greater Occipital Nerve Block With Bupivacaine for Acute Migraine [Phase 3]
A Phase 3 clinical trial evaluating greater occipital nerve block with bupivacaine for acute migraine has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2020-07-30Clinical Trial Update: PREMIUM Migraine Trial [NA]
A completed randomized trial update for the PREMIUM Migraine Trial sponsored by Abbott Medical Devices; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Adherence to and Beliefs on Recommendations for Behavioral Treatment for Migraine [NA]
Completed clinical trial evaluating adherence to and beliefs about recommendations for behavioral treatment for migraine; results posted in …
-
FDA approval · 2020-07-20FDA Approved: SUMATRIPTAN — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
The FDA approved a supplemental application for Sumatriptan from Sun Pharmaceutical Industries, resulting in changes to the product's labeli…
-
FDA approval · 2020-07-20FDA Approved: SUMATRIPTAN — Supplemental Application (Bionpharma Inc.)
The FDA approved a supplemental application for Sumatriptan from Bionpharma Inc. under the ANDA program, updating the regulatory status of t…
-
FDA approval · 2020-07-20FDA Approved: SUMATRIPTAN — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
The FDA approved a supplemental application for Sumatriptan submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2020-07-20FDA Approved: SUMATRIPTAN — Supplemental Application (Golden State Medical Supply, Inc.)
FDA approved a supplemental application for Sumatriptan submitted by Golden State Medical Supply, Inc., under the ANDA.
-
FDA approval · 2020-07-20FDA Approved: SUMATRIPTAN — Supplemental Application (ONESOURCE SPECIALTY PHARMA LIMITED)
FDA approved a supplemental application for SUMATRIPTAN from ONESOURCE SPECIALTY PHARMA LIMITED, approving a modification to the existing ge…
-
FDA approval · 2020-07-17FDA Approved: REYVOW — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Reyvow (lasmiditan) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2020-07-08Clinical Trial Update: A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine [Phase 3]
Phase 3 trial update for galcanezumab in adults with treatment-resistant migraine has completed with posted results.
-
FDA label_change · 2020-07-06FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for divalproex sodium from Zydus Pharmaceuticals USA Inc. to update the product labeling.
-
FDA approval · 2020-07-01FDA Approved: SUMATRIPTAN SUCCINATE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Sumatriptan succinate (Dr. Reddy's Laboratories Limited).